![The Top Line-logo](https://cdn-profiles.tunein.com/p1859380/images/logod.png?t=1)
The Top Line
Business & Economics Podcasts
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
Location:
United States
Description:
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
Language:
English
Website:
https://www.fiercepharma.com/
Email:
podcast@questex.com
A look at flu vaccine manufacturing and supply in the post-pandemic era
Duration:00:17:10
Driving flu vaccine uptake in the post pandemic era
Duration:00:20:46
The Crucial Role of HEK293 DNA Quantification in Biotherapeutics [Sponsored by Bio-Rad Laboratories]
Duration:00:13:42
What Chevron’s overturn means for biopharma
Duration:00:25:15
The TROP2 race for supremacy
Duration:00:24:41
A closer look at Fierce Biotech's Fierce 15
Duration:00:11:17
What 'The Next Berlin Patient' and a PrEP’s 100% efficacy mean for HIV drug development
Duration:00:26:38
Fierce 15: Where are they now?
Duration:00:10:02
Former FTC director weighs in on Novo's $16.5B deal with Catalent
Duration:00:17:18
Find out what to expect from the PDA/FDA Joint Regulatory Conference (Sponsored by Parenteral Drug Association)
Duration:00:13:45
A look at Big Pharma’s top-paid CEOs
Duration:00:10:47
The best biopharma M&A deals
Duration:00:15:02
A closer look at 'friend-shoring' and the drug shortage challenge
Duration:00:17:54
Inside this year’s ASCO: Biggest data drops, trends and the best exhibit booth
Duration:00:13:35
A look at the top 10 pharma drug ad spenders
Duration:00:09:35
A cell therapy reckoning
Duration:00:06:31
Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing (Part III)
Duration:00:39:37
[Sponsored] Opportunities & Challenges of Digital Pathology Adoption in CDx Development
Duration:00:17:00
[Sponsored] Unlocking health equity: The promise of digital health technologies
Duration:00:15:11
Advancements in cell & gene therapy manufacturing (Part II)
Duration:00:31:23